(Q43239046)

English

Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells

scientific article published on 19 November 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

based on heuristic

inferred from title

author name string

A Puissant

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

P Colosetti

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

G Robert

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

J-P Cassuto

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

S Raynaud

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

P Auberger

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

19 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

115-124

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Cell death in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Organelle-specific initiation of cell death pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Lysosomes and autophagy in cell death control

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Cysteine cathepsins: multifunctional enzymes in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

The anticancer drug imatinib induces cellular autophagy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Caspase-dependent cleavage of c-Abl contributes to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

21 January 2018

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.233

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.233

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43239046&oldid=2224534524"